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Abstract  Apart  from  the  risk  of  developing  glaucoma  there  is  also  the  risk  that  it  is  not
detected  and  irreversible  loss  of  vision  ensues.  Some  studies  of  methods  of  glaucoma  diag-
nosis have  examined  the  results  of  instrument-based  examinations  with  great  if  not  complete
reliance on  objective  ﬁndings  in  arriving  at  a  diagnosis.  The  very  valuable  advances  in  glau-
coma detection  instrument  technologies,  and  apparent  increasing  dependence  on  them,  may
have led  to  reduced  consideration  of  information  available  from  a  patient  history  in  those  stud-
ies. Dependence  on  objective  evidence  of  glaucomatous  pathology  may  reduce  the  possibility
of detecting  glaucoma  suspects  or  patients  at  risk  for  becoming  glaucoma  suspects.  A  valid
positive family  history  of  glaucoma  is  very  valuable  information.  However,  negative  family  his-
tories can  often  be  unreliable  due  to  large  numbers  of  glaucoma  cases  being  undiagnosed.  No
evidence  of  family  history  is  appropriate  rather  than  no  family  history.  In  addition  the  unrelia-
bility of  a  negative  family  history  is  increased  when  patients  with  glaucoma  fail  to  inform  their
family members.  A  ﬁnding  of  no  family  history  can  only  be  stated  as  no  known  family  history.
In examining  the  potential  diagnostic  contribution  from  a  patient  history,  this  review  consid-
ers, age,  frailty,  race,  type  and  degree  of  refractive  error,  systemic  hyper-  and  hypotension,
vasospasm,  migraine,  pigmentary  dispersion  syndrome,  pseudoexfoliation  syndrome,  obstruc-
tive sleep  apnea  syndrome,  diabetes,  medication  interactions  and  side  effects,  the  degree  of
exposure to  intraocular  and  intracranial  pressure  elevations  and  ﬂuctuations,  smoking,  and
symptoms  in  addition  to  genetics  and  family  history  of  the  disease.
© 2016  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).PALABRAS  CLAVE
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Historial  de  glaucoma  y  factores  de  riesgo
Resumen  Aparte  del  riesgo  de  desarrollar  glaucoma,  existe  también  el  riesgo  de  no  detec-
tarlo, con  la  consiguiente  pérdida  de  visión  irreversible  que  entran˜a.  Algunos  estudios  sobre  los
métodos para  diagnosticar  el  glaucoma  han  examinado  los  resultados  de  los  exámenes  basadosPlease  cite  this  article  in  press  as:  McMonnies  CW.  Glaucoma  history  and  risk  factors.  J  Optom.  (2016),
http://dx.doi.org/10.1016/j.optom.2016.02.003
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en  instrumentos,  que  dependen  casi  totalmente  de  los  hallazgos  objetivos  para  lograr  un  diag-
nóstico.  Los  muy  valiosos  avances  en  la  tecnología  instrumental  para  la  detección  del  glaucoma,
y el  incremento  aparente  de  la  dependencia  de  dichos  instrumentos,  pueden  haber  llevado  a
reducir la  consideración  de  la  información  disponible  en  la  historia  del  paciente  en  dichos  estu-
dios. La  dependencia  de  la  evidencia  objetiva  de  la  patología  glaucomatosa  puede  reducir  la
posibilidad  de  detectar  los  casos  de  sospecha  de  glaucoma,  o  los  pacientes  con  riesgo  de  pasar  a
la categoría  de  sospecha,  lo  que  puede  mejorar  los  resultados  de  la  supervisión  de  los  candidatos
a cirugía  refractiva.  Un  historial  familiar  de  glaucoma  positivo  y  válido  constituye  una  informa-
ción muy  valiosa.  Sin  embargo,  los  historiales  familiares  negativos  pueden  resultar  poco  ﬁables,
debido al  gran  número  de  casos  de  glaucoma  sin  diagnosticar.  La  falta  de  evidencia  de  historial
familiar es  más  apropiada  que  la  ausencia  de  historial  familiar.  Además,  la  poca  ﬁabilidad  de  los
historiales familiares  negativos  se  incrementa  cuando  los  pacientes  con  glaucoma  no  informan
a los  miembros  de  su  familia.  Un  hallazgo  de  ausencia  de  historial  familiar  puede  establecerse
únicamente  como  historial  familiar  desconocido.  Al  examinar  la  potencial  contribución  diagnós-
tica de  la  historia  del  paciente,  esta  revisión  considera  la  edad,  la  fragilidad,  la  raza,  el  tipo  y
grado de  error  refractivo,  la  hipertensión  e  hipotensión  sistémicas,  el  vasoespasmo,  la  migran˜a,
el síndrome  de  dispersión  pigmentaria,  el  síndrome  de  pseudo-exfoliación,  el  síndrome  de  apnea
obstructiva  del  suen˜o,  la  diabetes,  las  interacciones  medicamentosas  y  los  efectos  secundarios,
el grado  de  exposición  al  aumento  de  la  presión  intraocular  e  intracraneal,  el  tabaquismo,  y  los
síntomas,  además  de  los  factores  genéticos  y  el  historial  familiar  de  la  enfermedad.
© 2016  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.U.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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wGlaucoma  involves  a  progressive  loss  of  retinal  ganglion
ells  (RGC)  and  characteristic  changes  in  neuroretinal  rim
issue  in  the  optic  nerve  head  (ONH)  which  are  accompanied
y  visual  ﬁeld  (VF)  constriction.1 There  are  several  types
f  glaucoma  constituting  a  group  of  eye  diseases  which  are
he  leading  cause  of  irreversible  blindness  worldwide.2 Apart
rom  the  risk  of  developing  glaucoma  there  is  the  risk  that
t  is  not  detected  and  irreversible  loss  of  vision  ensues.1 In
 sample  of  5000  urban  Greek  people  over  59  years  of  age,
7.1%  of  glaucoma  cases  were  found  to  be  undiagnosed.3 A
tudy  of  3654  predominantly  white  Australians  (90.2%  over
0  years  of  age  and  24%  over  80  years  of  age)  found  that
he  prevalence  of  POAG  was  3.0%  with  51%  not  having  been
reviously  diagnosed.4 That  so  many  cases  of  glaucoma  can
e  undiagnosed  means  that  studies  based  in  hospitals  or
pecialist  clinics,  for  example,  can  be  biased  to  particu-
ar  classes  of  referred  patients  and  so  not  representative
f  the  Glaucoma  cohort5 which  should  ideally  include  all  the
ndiagnosed  cases.  Identiﬁcation  of  the  risk  factors  for  glau-
oma  development  requires  population-based  studies.5 The
revalence  or  incidence  of  glaucoma  in  a  population  study
ill  depend  on  the  thoroughness  of  the  examination  regime
mployed.
Comprehensive  history  ﬁndings  may  make  an  important
ontribution  to  the  valuable  identiﬁcation  of  glaucoma  sus-
ects  prior  to  any  evidence  of  glaucomatous  changes.  Apart
rom  diagnostic  potential,  decisions  about  treatment  and
ollow-up  schedules  may  be  improved  by  reference  to  his-Please  cite  this  article  in  press  as:  McMonnies  CW.  Gl
http://dx.doi.org/10.1016/j.optom.2016.02.003
ory  ﬁndings  indicating  risk  for  and  likely  speed  of  glaucoma
rogression  for  example.  The  ﬁndings  of  a  thorough  his-
ory  may  aid  decisions  about  the  range  of  objective  testing
c
c
gequired  during  a  clinical  examination.  The  potential  for  his-
ory  to  contribute  to  diagnosis  and  patient  management  may
e  critically  more  evident  when  objective  testing  indicates
orderline  or  conﬂicting  diagnostic  ﬁndings.  Screening  of
igher-risk  groups  may  be  the  most  cost-effective  method  of
educing  the  volume  of  undiagnosed  glaucoma6 and  patient
istory  appears  to  be  a  practical  means  of  screening  to  iden-
ify  the  higher  risk  target  population.
Various  combinations  of  patient  history  and  objective
ethods  for  the  evaluation  of  the  ONH,  retinal  nerve  ﬁbre
ayer  (RNFL),  VFs,  tonometry,  corneal  thickness,  tonogra-
hy  and  provocative  testing,  for  example,  can  be  used
o  classify  subjects  as  healthy,  glaucoma  suspects  or  hav-
ng  glaucomatous  pathology.  A  patient’s  family  history  may
mprove  the  accuracy  of  glaucoma  patient  diagnostic  clas-
iﬁcation  in  population  studies  as  well  as  diagnosis  in  a
linical  setting.7 In  a  general  medical  outpatient  setting,
 correct  diagnosis  was  found  to  be  determined  in  82.5%
f  cases  based  on  the  information  provided  by  a  medical
istory.8 There  is  a  wide  range  of  supplementary  infor-
ation  in  a  patient  history  which  may  improve  glaucoma
iagnosis  and  treatment  decisions.  However,  except  for
atient  age  in  some  cases,  the  ﬁndings  of  a  patient  his-
ory  may  not  be  included  in  glaucoma  studies.9--13 Some
tudies  may  include  the  use  of  only  family  history  rather
han  a  full  patient  history.14--16 Other  studies  may  be  limited
o  objective  ﬁndings  from  instrument-based  examinations
ith  reliance  on  objective  ﬁndings  to  determine  diagnosticaucoma  history  and  risk  factors.  J  Optom.  (2016),
lassiﬁcations  without  reference  to  history  or  other  clini-
al  ﬁndings.  For  example,  accuracy  of  diagnosis  of  early
laucoma  was  found  to  be  greatest  (although  not  always
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Glaucoma  risk  factors  
signiﬁcantly  so)  for  ocular  coherence  tomography  (OCT)
RNFL  thickness  parameters,  followed  by  Frequency-Doubling
Technology  VF  anomalies,  Scanning  Laser  Polarimetry  RNFL
anomalies,  and  lastly  Short-Wavelength  Automated  Peri-
metric  VF  anomalies.9 However,  dependence  on  signiﬁcant
evidence  of  glaucomatous  pathology  reduces  the  capacity
to  detect  glaucoma  suspects.  The  emphasis  on  the  very
valuable  advances  in  the  technology  of  glaucoma  detec-
tion  instruments,  and  associated  increasing  applications  for
them,  could  lead  to  reduced  attention  being  given  to  infor-
mation  available  from  a  patient  history.  In  a  study  by  Miki
and  coauthors  glaucoma  suspects  were  deﬁned  as  those  hav-
ing  glaucomatous  optic  neuropathy,  or  suspicious-appearing
optic  discs  based  on  stereophotograph  review  by  two  experi-
enced  graders,  or  ocular  hypertension  (intraocular  pressure
(IOP)  >21  mmHg  at  baseline  without  evidence  of  repeatable
glaucomatous  visual  ﬁeld  defect  (VFD)  at  baseline.17 That
study  found  that  the  rate  of  RNFL  loss  over  time  may  be
a  useful  tool  to  help  identify  patients  who  are  at  risk  for
developing  VF  loss.17 Such  results  may  be  interpreted  as  indi-
cating  that  OCT  alone  is  a  suitable  method  of  examination.
However,  notwithstanding  the  usefulness  of  these  ﬁndings,
the  question  remains  as  to  whether  a  comprehensive  patient
history  could  have  identiﬁed  more  subjects  at  risk  for  hav-
ing  reduced  RNFL  thickness  and  VF  loss.  Case  detection
can  be  improved  by  combining  RNFL  thickness  analysis  with
visual  function  tests.18 However  this  review  re-evaluates  the
potential  for  patient  history  to  also  contribute  to  the  diag-
nosis  of  glaucoma  and  glaucoma  suspects.  The  detection  of
glaucoma  suspects  depends  on  patient  history  when  there  is
no  detectable  objective  evidence  of  glaucoma.
Increased  monitoring  of  glaucoma  patients  reduces  the
risk  of  undetected  progression.19 Use  of  dynamic  and  per-
sonalised  testing  schedules  can  enhance  the  efﬁciency
of  detecting  open-angle  glaucoma  (OAG)  progression  and
reduce  diagnostic  delay  compared  with  ﬁxed  yearly  mon-
itoring  intervals.19 Ideally,  monitoring  schedules  could  be
determined  according  to  individual  risk  of  developing  or  pro-
gressing  glaucoma.  The  performance  of  a  forecasting  model
might  be  improved  by  consideration  of  any  signiﬁcant  factors
revealed  by  patient  history.  This  review  examines  history
details  which  may  help  determine  diagnostic  classiﬁcations
as  well  as  help  determine  individual  treatment  and  follow-
up  schedules  according  to  the  risk  and  anticipated  rate  of
subsequent  progression.  PubMed  searches  for  ‘glaucoma  sus-
pects’  and  ‘glaucoma  examination’  as  well  as  for  ‘glaucoma
suspects’  and  ‘glaucoma  diagnosis’  yielded  119  and  500  ref-
erences  respectively.  The  most  relevant  of  these  to  this
review  have  been  cited.
Age and  frailty
Glaucoma  risk  increases  with  age.20--22 As  a  consequence,
glaucoma  can  be  expected  to  be  associated  with  other  age-
related  diseases  such  as  macular  degeneration,20 vascular
diseases,23 and  obstructive  sleep  apnea24 for  example.  How-
ever  this  is  not  a  direct  link  for  most  age-related  diseases.Please  cite  this  article  in  press  as:  McMonnies  CW.  Gl
http://dx.doi.org/10.1016/j.optom.2016.02.003
The  concept  of  frailty  is  a  non-speciﬁc  state  of  vulnerabil-
ity  which  results  in  a  higher  risk  for  accelerated  physical
and  cognitive  decline,  disability  and  death.25 Assessment  of
frailty  depends  on  the  accumulation  of  health  deﬁcits26 such
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3
s  hypertension,  hypotension,  diabetes,  migraine,  obstruc-
ive  sleep  apnea  syndrome,  cataracts,  glaucoma  and  the
eed  for  medications.27 As  is  the  case  for  glaucoma,  the
revalence  of  many  other  health  problems  tends  to  increase
ith  frailty  and  may  be  an  important  reason  for  their  concur-
ence  in  some  patients.  A  frail  patient  at  a  younger  age  may
ave  greater  risk  for  developing  glaucoma.
ender
n  the  Ocular  Hypertension  Treatment  (OHT)  study,  male
ender  was  found  by  univariate  analysis  to  be  a  useful
redictor  for  the  onset  of  primary  open  angle  glaucoma
POAG).28 A  Bayesian  meta-analysis  found  that  men  were
ore  likely  to  have  OAG  with  the  reservation  that  gen-
er  inﬂuence  depends  on  the  deﬁnition  of  glaucoma.29 For
xample,  a  review  of  the  literature  concluded  that  women
re  at  higher  risk  for  angle-closure  glaucoma  (ACG)  but  that
here  is  no  clear  gender  predilection  for  OAG.30 These  ﬁnd-
ngs  may  only  be  relevant  to  the  groups  studied.  That  women
sually  live  longer  than  men  increases  their  risk  for  glaucoma
nd  glaucoma  blindness.29
enetics and family history
vidence  of  the  signiﬁcance  of  Myocilin  mutations  in
dvanced  primary  open  angle  glaucoma  (POAG)31 and  copy
umber  variations  of  TBK1  in  normal  tension  glaucoma
NTG)32 illustrate  the  diagnostic  potential  for  genetic  test-
ng.  However,  the  contribution  of  genetics  in  glaucoma  risk
rediction  has  usually  been  limited  to  knowledge  of  family
istory33 although,  too  often,  patients  are  unaware  of  family
embers  who  have  been  diagnosed  with  glaucoma.34 That
ore  than  50%  of  glaucoma  cases  can  be  undiagnosed3 adds
o  the  unreliability  of  family  history.  A  family  history  of  glau-
oma  was  found  to  carry  a  relative  risk  of  2.1  times  for  being
ssociated  with  at  least  possible  OAG20 However,  the  rela-
ive  importance  of  family  history  may  vary  according  to  the
loseness  of  relationship  of  a  patient  to  an  affected  family
ember  (ﬁrst.  second  or  even  third  degree).35 Around  half
f  all  primary  OAG  patients  have  a  positive  family  history,
nd  their  ﬁrst  degree  relatives  (parents,  siblings  or  children)
ave  an  approximately  9-fold  increased  risk  of  developing
laucoma.32 Wolfs  and  co-authors  found  that  the  ﬁrst  degree
elatives  of  glaucoma  patients  were  found  to  have  a  22%  life-
ime  risk  of  glaucoma  themselves  in  comparison  to  2.3%  in
elatives  of  normal  controls.36 The  prevalence  of  glaucoma
as  10.4%  in  the  siblings  of  glaucoma  patients  compared  to
.7%  in  the  siblings  of  normal  controls.36 In  addition,  the  risk
f  inheriting  glaucoma  may  increase  with  the  number  of  rel-
tives  diagnosed  with  the  disease.  Approximately  60%  of  a
laucoma  patient  sample  was  found  to  belong  to  families  in
hich  other  members  have  the  disease.7
ace
 review  of  the  ﬁndings  from  11  population-based  studiesaucoma  history  and  risk  factors.  J  Optom.  (2016),
ound  a  wide  range  in  the  prevalence  of  POAG  among
opulations  of  the  ‘‘same  race’’.37 Variable  prevalence
eported  in  different  studies  may  have  been  due  to  different
ethods  of  examination  as  well  as  being  a  consequence  of
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ifferences  in  exposure  to  geographic,  social,  behavioural
nd  environmental  factors.37 For  certain  age  groups  Racette
nd  co-authors  estimated  the  prevalence  of  POAG  in  a  black
merican  population,  to  be  six  times  higher  compared
o  whites.38 Although  black  populations  have  the  highest
revalence  of  OAG,  white  populations  showed  the  steepest
ncrease  in  OAG  prevalence  with  age.29 A  higher  glaucoma
revalence  has  been  found  in  Asian  populations  including  a
igher  incidence  of  primary  angle-closure  glaucoma  (ACG)
ompared  to  white  patients.39
yopia
yopia  has  been  found  to  be  a  signiﬁcant  risk  factor  for
laucoma.21,39--44 That  myopia  is  a  risk  factor  for  glaucoma
nd  that  it  is  also  more  prevalent  among  Asian  patients  may
elp  explain  increased  prevalence.39 In  addition,  that  high
yopia42 and  increased  axial  length  in  certain  age  groups
ave  both  been  identiﬁed  as  risk  factors43,44 suggests  that
he  risk  of  glaucoma  development  and  progression  increases
ith  the  degree  of  myopia.44
he type of glaucoma may vary with refractive
rror
he  signiﬁcance  of  history  items  may  vary  with  the  type  of
laucoma.  For  example,  risk  factors  for  acute  ACG  include
yperopia45 and  myopia  is  a  signiﬁcant  history  item  for  pro-
ression  of  ocular  hypertension  (OHT)  and  POAG.40
ystemic hypotension and hypertension
ystemic  hypertension,  vasospasm,  and  acute  hypotension
ave  been  proposed  as  potential  risk  factors  for  glaucoma
n  clinic-based  studies.46--48 Several  studies  have  reported
ssociations  between  low  diastolic  pressure,  lower  ocu-
ar  perfusion  pressure  (OPP)  and  higher  prevalence  and/or
ncidence  of  glaucoma.46--49 Low  systemic  blood  pressure
BP),  especially  when  combined  with  an  elevated  IOP,  will
ower  OPP  and  risk  a  reduction  in  the  volume  of  blood
ow  to  the  ONH  in  eyes  with  an  impaired  auto-regulatory
ystem,50 leading  to  ischaemic  and  reperfusion  oxidative
tress  damage  to  the  axons  and  associated  atrophy  of  the
GCs.  A  history  of  antihypertensive  treatment  and  associ-
ted  lower  BP  could  increase  the  risk  of  glaucoma  by  this
echanism.51 The  Blue  Mountains  population  study  found
hat  mean  IOP  increased  linearly  from  14.3  mmHg  for  systolic
P  <110  mmHg  to  17.7  mmHg  for  systolic  BP  >200  mmHg.52 A
tudy  of  4297  subjects  over  40  years  of  age  in  a  deﬁned
redominantly  white  population  found  a  positive  corre-
ation  between  systemic  BP  and  IOP  and  an  association
etween  POAG  and  systemic  hypertension.47 However,  a
ross-sectional  population  study  concluded  that  the  associ-
tion  between  hypertension  and  POAG  was  most  likely  due
o  the  correlation  between  age  and  hypertension.21Please  cite  this  article  in  press  as:  McMonnies  CW.  Gl
http://dx.doi.org/10.1016/j.optom.2016.02.003
asospasm
asospasm  represents  vascular  dysregulation  associated
ith  inappropriate  constriction  or  insufﬁcient  dilatation  in
t
a
a
a PRESS
C.W.  McMonnies
he  microcirculation.53 The  eye  is  frequently  involved  in  a
asospastic  syndrome  with  vasospasm  associated  with  ante-
ior  ischaemic  optic  neuropathy  and  glaucoma.53 Vasospasm
s  often  falsely  equated  with  Raynaud’s  phenomenon.53
asospasm  patients  often  present  with  cold  hand  symptoms
ut  they  usually  do  not  have  the  pale  ﬁngers  which  are
haracteristic  of  Raynaud’s  disease.53 Vasospasm  patients
requently  have  low  BP53 which,  as  discussed,  may  also  be
ssociated  with  reduced  OPP  and  glaucoma  risk.
igraine
n  association  between  NTG  and  migraine  has  been  sug-
ested,  with  a  potential  common  vascular  aetiology  for
oth  diseases.54 However,  an  association  between  OAG  and
igraine  was  found  to  only  be  signiﬁcant  for  subjects  aged
0--79  years.55
igmentary dispersion syndrome
igmentary  glaucoma  characteristically  develops  in  young
yopic  patients  with  pigmentary  dispersion  syndrome.56
ale  gender,  black  race,  severe  myopia,  and  Krukenberg
pindles  were  identiﬁed  as  possible  risk  factors  for  the  devel-
pment  and  severity  of  glaucoma  in  the  pigment  dispersion
yndrome.57
seudoexfoliation syndrome
seudoexfoliation  syndrome  is  a  common  age-related  gen-
ralised  ﬁbrotic  matrix  process58 with  signiﬁcance  because
t  increases  the  risk  of  developing  glaucoma.20,22
bstructive sleep apnea syndrome
ompared  to  normal  patients,  obstructive  sleep  apnea  syn-
rome  patients  were  found  to  have  1.67  times  greater
ikelihood  of  developing  glaucoma  over  a  5  year  follow-up
eriod.24
iabetes
 meta-analysis  by  Zhou  and  co-authors  found  that  six  case-
ontrol  studies  indicated  diabetes  as  a  risk  factor  for  POAG
ith  a mean  odds  ratio  greater  than  one,  while  a  seventh
tudy  found  an  odds  ratio  of  0.61.59 Of  six  population-
ased  cohort  studies  ﬁve  indicated  a  signiﬁcant  association
etween  diabetes  mellitus  and  POAG.52 It  appears  that
iabetes  may  increase  the  risk  of  POAG,  especially  as  hyper-
lycaemia  results  in  heightened  sensitivity  to  IOP  and  risk  of
euronal  injury.53 When  80  NTG  and  4015  control  patients
ere  compared  in  a  Korean  population,  a  higher  propor-aucoma  history  and  risk  factors.  J  Optom.  (2016),
ion  of  fasting  capillary  glucose  ≥200  mg/dL  was  identiﬁed
s  a  risk  factor  for  OAG  in  both  univariate  and  multivariate
nalyses.35 Nevertheless,  the  association  between  diabetes
nd  glaucoma  remains  controversial.60
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Glaucoma  risk  factors  
Medication-related IOP elevation
The  concomitant  use  of  glaucoma  and  systemic  medications
for  co-existing  systemic  disorders  creates  the  potential  for
drug  interactions,  as  well  as  side  effects  from  both  groups
of  drugs.61 For  example,  ACG  due  to  pupillary  block,  can
be  caused  by  local  or  systemic  administration  of  adrenergic
agents,  as  well  as  by  sulfa-based  drugs62 Corticosteroid-
induced  glaucoma  and  OHT  is  a  response  to  increased
resistance  to  aqueous  outﬂow.63 Treatment  for  systemic
hypertension  or  Raynaud’s  disease  could  increase  the  risk
of  glaucoma.51 For  example,  a  ﬁve  year  follow-up  of  3271
subjects  found  the  risk  factors  associated  with  the  incidence
of  POAG  development  included  having  ever  taken  calcium-
channel  or  alpha-blocker  medication.20 However,  whether
alpha-blocking  medications  have  any  haemodynamic  inﬂu-
ence  on  the  ONH  remains  to  be  elucidated.20
Smoking
Studies  of  the  association  between  glaucoma  and  smok-
ing  have  been  contradictory.60 It  has  been  hypothesised
that,  in  the  presence  of  genetic  risk  factors,  exposure  to
environmental  stresses  such  as  smoking,  corticosteroid  med-
ication  and  diabetes,  results  in  an  earlier  age  of  onset  of
glaucoma.60 The  risk  of  glaucoma  in  smokers  may  be  higher
in  men.60
Exposure to IOP elevation and ﬂuctuation
IOP  is  the  only  known  modiﬁable  factor  in  OAG.12 One  of
the  factors  associated  with  progression  of  glaucoma  is  ﬂuc-
tuation  in  IOP  either  over  the  24  h  diurnal  period  or  across
visits.64--67 For  example,  in  NTG  patient’s  progression  of  VF
losses  was  found  to  be  associated  with  a  higher  24  h  peak
IOP  and  greater  IOP  ﬂuctuation  over  24  h.68 Exposure  to
IOP  elevations  and  ﬂuctuations  which  occur  during  a  vari-
ety  of  regular  or  occasional  activities  may  increase  the
risk  for  the  development  or  progression  of  glaucoma.69--71
For  example  activities  involving  sleep-related  postures,71
lid  squeezing/squinting,  eye  wiping,  massaging  or  rubbing,
inverted  body  positions  (such  as  in  the  practice  of  Yoga),
wearing  swimming  goggles,  muscular  effort,  increased  expi-
ratory  effort  such  as  during  physical  exercise  or  when
playing  high  wind  resistant  musical  instruments,  and  wear-
ing  a  shirt  or  tie  which  are  tight  around  the  neck  are
all  known  to  elevate  IOP,67 sometimes  in  conjunction  with
intracranial  pressure  elevation.72 Reducing  participation  in
activities  which  elevate  either  or  both  IOP  and  intracranial
pressure  will  decrease  exposure  to  higher  levels  of  lamina
cribrosa  displacement  and/or  lamina  cribrosa  compression
with  the  associated  possibility  of  risk  of  damage  to  RNFL
axons  passing  through  the  lamina  cribrosa.72 Although  a
single  short-term  ﬂuctuation  is  likely  to  be  of  negligible
signiﬁcance,  the  cumulative  effect  of  constant  or  frequent
ﬂuctuation  could  be  signiﬁcant  in  contributing  to  glaucoma
pathogenesis.73 Any  risk  associated  with  a  single  short-Please  cite  this  article  in  press  as:  McMonnies  CW.  Gl
http://dx.doi.org/10.1016/j.optom.2016.02.003
term  ﬂuctuation  may  increase  with  the  degree  of  elevation
involved.  IOP  measured  with  the  patient  sitting  with  neck  in
a  neutral  position  (no  ﬂexion  or  extension)  is  probably  the
lowest  of  any  body  position.74 Estimation  of  the  degree  of
a
r
p
C PRESS
5
xposure  to  IOP  elevation  and  ﬂuctuation  episodes,  some-
imes  to  levels  many  times  the  sitting-position  level,  can  be
ided  by  questionnaire  responses.67 (Copies  of  the  question-
aire  can  be  obtained  from  c.mcmonnies@unsw.edu.au.)
ymptoms
laucoma  progression  carries  a  burden  of  both  nonvisual
nd  visual  symptoms  which  are  a  considerable  concern  to
atients  in  more  advanced  cases.75 However,  at  the  time
f  diagnosis,  most  patients  are  relatively  free  of  glaucoma-
nduced  impairments.76 The  absence  of  symptoms  which  are
peciﬁc  to  early  glaucoma  appears  likely  to  contribute  to
he  high  number  of  undiagnosed  subjects  found  in  popu-
ation  studies.75,76 The  Glaucoma  Symptom  Scale  provides
 valid  and  reliable  estimate  of  symptoms  associated  with
laucoma  and  its  treatments.75 However,  for  the  early  stages
f  glaucoma,  sensitivity  may  be  high  and  speciﬁcity  corre-
pondingly  low  with  this  instrument  because  many  of  the
laucoma  Scale  symptoms  such  as  burning,  smarting,  sting-
ng,  tearing,  dryness,  itching,  soreness  and  tiredness75 can
ccur  in  many  diseases  such  as  any  of  the  dry  eye  syn-
romes,  and  even  in  otherwise  healthy  eyes  during  exposure
o  adverse  environmental  conditions.  However,  these  types
f  symptoms  may  occur  as  a  consequence  of  glaucoma  treat-
ent.  In  both  clinical  and  research  settings  this  scale  should
rove  to  be  a  valuable  patient-centred  tool  for  the  assess-
ent  and  comparison  of  symptoms  experienced  by  patients
ith  glaucoma  especially  perhaps  for  those  who  present  with
ew  symptoms  while  undergoing  treatment.75
iscussion
omprehensive  history  ﬁndings  may  make  an  important
ontribution  to  the  identiﬁcation  of  glaucoma  suspects  prior
o  any  evidence  of  glaucomatous  changes.  The  ﬁndings  of
 thorough  history  may  aid  decisions  about  the  range  of
bjective  testing  required  during  a  clinical  examination.
he  potential  value  for  a  comprehensive  history  in  deci-
ion  making  may  be  greater  when  objective  testing  indicates
orderline  or  conﬂicting  diagnostic  ﬁndings.  For  example,
CT  using  guided  progression  analysis  software,  perimetry
nd  stereophotography  examinations  were  repeated  dur-
ng  follow-up  to  examine  for  glaucomatous  progression  in
46  eyes.13 Notwithstanding  some  agreement  between  the
hree  methods,  most  cases  with  detectable  changes  were
dentiﬁed  by  only  one  of  these  methods  of  examination.
hese  ﬁndings  suggest  that  reference  to  history  informa-
ion  may  assist  decision  making  when  glaucoma  monitoring
xamination  ﬁndings  obtained  with  different  instruments
re  not  in  agreement  or  are  at  a  borderline  level  in  regard
o  recommended  diagnostic  cut-offs  for  particular  instru-
ents.  It  is  important  to  stress  that  a  predictive  instrument
uch  as  a  comprehensive  history15 as  well  as  an  instrument-
ased  objective  predictive  risk  model  should  always  be
upplemented  by  clinical  judgement.12 The  need  for  clinical
udgement  may  be  reduced  if  it  was  possible  to  appropri-aucoma  history  and  risk  factors.  J  Optom.  (2016),
tely  weight  the  signiﬁcance  of  individual  history  items  in
elation  to  glaucoma  diagnosis  in  order  that  the  combined
redictive  performance  of  a  history  could  be  maximised.
ombining  multiple-screening  strategies  together  with
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amily  history  can  be  a  very  powerful  diagnostic  method
or  glaucoma.15 No  evidence  of  a  family  history  can  be  an
ppropriate  ﬁnding  whereas  a  ﬁnding  of  no  family  history
annot  be  made  conﬁdently.  However,  given  its  potential
or  unreliability,  rather  than  considering  only  the  pres-
nce  of  a  family  history  of  glaucoma,  the  combination  of
 comprehensive  history  and  clinical  assessment20 may  be
ore  successful,  especially  in  marginal/suspect  diagnoses.
enetic  variations  related  to  OAG  may  provide  additional
ndication  of  risk.77 Apart  from  diagnostic  potential,  treat-
ent  and  the  appropriateness  of  follow-up  schedules  may
e  improved  by  reference  to  history  ﬁndings.  For  example,
 patient’s  history  may  also  contribute  to  difﬁcult  manage-
ent  decisions  in  cases  of  ocular  hypertension.  Screening  of
igher-risk  groups  may  be  the  most  cost-effective  method  of
educing  the  volume  of  undiagnosed  glaucoma78 and  patient
istory  appears  to  be  a  practical  means  of  helping  to  iden-
ify  patients  with  higher  risk  for  developing  glaucoma.  As  a
ossible  consequence  of  the  importance  placed  on  objec-
ive  ﬁndings  in  recent  literature,  the  potential  usefulness
f  history  ﬁndings  may  sometimes  be  ignored  or  under-
mphasised.
unding
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